Freedom Capital sets USD 36.00 target for HealthStream stock

Published on 10/15/2026 at 19:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 12.5 percent to USD 83.73 million. HealthStream stock costs EUR 30.00 on October 15, 2026, 0.04 percent below Nasdaq close.

Freedom Capital target guides valuation

Freedom Capital began coverage with a USD 36.00 target and Hold rating on October 13, 2026.
Second-quarter revenue rose 12.5 percent to USD 83.73 million.
HealthStream stock costs EUR 30.00 at Lang & Schwarz on October 15, 2026 at 7:46 p.m. CEST, 0.04 percent below the Nasdaq prior close.
HealthStream carried a market capitalization of USD 1.0 billion as of October 15, 2026.

HSTM, US42222N1037, Illustration mit AI erstellt.

Freedom Capital began coverage of HealthStream with a Hold rating and a USD 36.00 price target on October 13, 2026, according to Markets Insider. Against the Nasdaq price of USD 33.63, the target stands 7.05 percent higher. HealthStream stock was trading at EUR 30.00 at Lang & Schwarz on October 15, 2026 at 7:46 p.m. CEST, 0.04 percent below the Nasdaq prior close.

Revenue growth sets the operating baseline

HealthStream generated USD 83.73 million in revenue in the second quarter of 2026, up 12.5 percent from the year-earlier period. Adjusted earnings per share came to USD 0.23, compared with a consensus estimate of USD 0.17, while revenue exceeded the USD 80.82 million expectation, according to MarketBeat. The finance figures show net income of USD 6.67 million and a net margin of 8.00 percent for the quarter ended June 30, 2026.

HealthStream stock stays near its yearly high

The Nasdaq quotation stood at USD 33.63 at 1:56 p.m. ET on October 15, 2026. HealthStream's 52-week range was USD 19.50 to USD 34.48, placing the price 2.47 percent below the high. Trading volume was 47,583 shares against an average of 193,975 shares.

Valuation and upcoming dates

HealthStream had a market capitalization of USD 1.0 billion, a price-to-earnings ratio of 47.01 and no trailing dividend yield in the finance figures dated October 15, 2026. Freedom Capital's Hold rating reflects valuation rather than a lack of operating growth: the USD 36.00 target is 7.05 percent above the Nasdaq price. The company identifies Nasdaq as its listing venue and describes workforce development, learning, credentialing and provider solutions as its main activities on its HealthStream investor-relations page.

Comparison with peers

HealthStream (Nasdaq, USD): minus 0.04 percent, P/E 47.01, market capitalization USD 1.0 billion

Doximity (NYSE, USD): plus 4.50 percent, P/E 36.81, market capitalization USD 5.6 billion

Definitive Healthcare (Nasdaq, USD): plus 0.93 percent, P/E minus 0.62, market capitalization USD 106.2 million

Price position for investors

The main contrast is clear: HealthStream's second-quarter revenue growth was stronger than the consensus comparison, but its valuation remains higher than the USD 36.00 target framework implies. The stock's position 2.47 percent below its yearly high leaves limited room for a fresh high before the next company update.

HealthStream was trading at EUR 30.00 at Lang & Schwarz on October 15, 2026 at 7:46 p.m. CEST, 0.04 percent below the Nasdaq prior close. The further course of trading is shown by the continuously updated real-time quote of HealthStream stock.